Loading…
Down‐regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP‐2 and inducing mesenchymal‐to‐epithelial transition
Vasculogenic mimicry (VM) constitutes a novel approach for tumour blood supply and contributes to tumour metastasis and poor prognosis in patients with melanoma. Myoferlin (MYOF), a type II membrane protein involved in membrane regeneration and repair, is elevated in several malignant tumours, espec...
Saved in:
Published in: | Journal of cellular and molecular medicine 2018-03, Vol.22 (3), p.1743-1754 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c5145-2c1b50478c560ed14d39dbf2e9c6e63d9eff1c3231a10986a6637f0bc80579373 |
---|---|
cites | cdi_FETCH-LOGICAL-c5145-2c1b50478c560ed14d39dbf2e9c6e63d9eff1c3231a10986a6637f0bc80579373 |
container_end_page | 1754 |
container_issue | 3 |
container_start_page | 1743 |
container_title | Journal of cellular and molecular medicine |
container_volume | 22 |
creator | Zhang, Wenxue Zhou, Ping Meng, Ai Zhang, Rongxin Zhou, Yan |
description | Vasculogenic mimicry (VM) constitutes a novel approach for tumour blood supply and contributes to tumour metastasis and poor prognosis in patients with melanoma. Myoferlin (MYOF), a type II membrane protein involved in membrane regeneration and repair, is elevated in several malignant tumours, especially in advanced melanomas. This study aims to investigate the role and mechanism of MYOF in the regulation of VM. VM structures were found in 14 of 52 tested melanoma samples, and high MYOF expression correlated with VM structures. According to Kaplan–Meier survival curves, VM channels and elevated MYOF expression both correlated with poor prognosis in melanoma patients. Down‐regulation of MYOF by siRNA severely impaired the capability of A375 cells to form VM structures in vitro. Further studies demonstrated MYOF knockdown inhibited cell migration and invasion, which is required for VM formation, via decreasing MMP‐2 expression as evidenced by Western blotting, RT‐RCP and ELISA results. SB‐3CT, a specific inhibitor of MMP‐2, showed similar inhibiting effects with siMYOF, further supporting that MYOF down‐regulation inhibits MMP‐2 expression to affect VM formation. Moreover, MYOF knockdown suppress VM formation by A375 cells by inducing mesenchymal‐to‐epithelial transition (MET). After down‐regulating MYOF, focal adhesions were enlarged and A375 cells developed into a clear epithelial morphology. Such cells acquired the expression of E‐cadherin at adherens junctions along with a loss of mesenchymal markers, such as Vimentin and Twist1. In conclusion, MYOF plays an important role in VM and knockdown of MYOF suppresses VM formation via decreasing MMP‐2 and inducing MET in A375 melanoma cells. |
doi_str_mv | 10.1111/jcmm.13455 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5824422</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2007380084</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5145-2c1b50478c560ed14d39dbf2e9c6e63d9eff1c3231a10986a6637f0bc80579373</originalsourceid><addsrcrecordid>eNp9kctu1DAUhiMEoqWw4QGQJTYIaVo7dpx4g1QNlxZ1BAtYW45zMuORL4OdTJUdj8COLc_Co_AkeDrTCljghW35fPp0fP6ieErwKcnrbK2dOyWUVdW94phUTTljgrL7hztpaHNUPEppjTHlhIqHxVEpCGc158fF99fh2v_6-i3CcrRqMH6JFlPoIVrjkfEr05ohoWEFaKuSHm1YgjcaOeOMjhMK_c8fDqzywSm0NQp1oCOodONZfMziEinfZVM36t2jgwReryanbC4OIW-wMdlvjbJoiMonM5jgHxcPemUTPDmcJ8Xnt28-zS9mVx_eXc7Pr2a6IqyalZq0FWZ1oyuOoSOso6Jr-xKE5sBpJ6DviaYlJYpg0XDFOa173OoGV7WgNT0pXu29m7F10GnwuQcrN9E4FScZlJF_V7xZyWXYyjxaxsoyC14cBDF8GSEN0pmkweaZQBiTJILXjHMhmow-_wddhzH6_D1ZYlzTBuOGZerlntIxpBShv2uGYLnLW-7yljd5Z_jZn-3fobcBZ4DsgWtjYfqPSr6fLxZ76W-s0L5P</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2007380084</pqid></control><display><type>article</type><title>Down‐regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP‐2 and inducing mesenchymal‐to‐epithelial transition</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Open Access: Wiley-Blackwell Open Access Journals</source><creator>Zhang, Wenxue ; Zhou, Ping ; Meng, Ai ; Zhang, Rongxin ; Zhou, Yan</creator><creatorcontrib>Zhang, Wenxue ; Zhou, Ping ; Meng, Ai ; Zhang, Rongxin ; Zhou, Yan</creatorcontrib><description>Vasculogenic mimicry (VM) constitutes a novel approach for tumour blood supply and contributes to tumour metastasis and poor prognosis in patients with melanoma. Myoferlin (MYOF), a type II membrane protein involved in membrane regeneration and repair, is elevated in several malignant tumours, especially in advanced melanomas. This study aims to investigate the role and mechanism of MYOF in the regulation of VM. VM structures were found in 14 of 52 tested melanoma samples, and high MYOF expression correlated with VM structures. According to Kaplan–Meier survival curves, VM channels and elevated MYOF expression both correlated with poor prognosis in melanoma patients. Down‐regulation of MYOF by siRNA severely impaired the capability of A375 cells to form VM structures in vitro. Further studies demonstrated MYOF knockdown inhibited cell migration and invasion, which is required for VM formation, via decreasing MMP‐2 expression as evidenced by Western blotting, RT‐RCP and ELISA results. SB‐3CT, a specific inhibitor of MMP‐2, showed similar inhibiting effects with siMYOF, further supporting that MYOF down‐regulation inhibits MMP‐2 expression to affect VM formation. Moreover, MYOF knockdown suppress VM formation by A375 cells by inducing mesenchymal‐to‐epithelial transition (MET). After down‐regulating MYOF, focal adhesions were enlarged and A375 cells developed into a clear epithelial morphology. Such cells acquired the expression of E‐cadherin at adherens junctions along with a loss of mesenchymal markers, such as Vimentin and Twist1. In conclusion, MYOF plays an important role in VM and knockdown of MYOF suppresses VM formation via decreasing MMP‐2 and inducing MET in A375 melanoma cells.</description><identifier>ISSN: 1582-1838</identifier><identifier>EISSN: 1582-4934</identifier><identifier>DOI: 10.1111/jcmm.13455</identifier><identifier>PMID: 29164766</identifier><language>eng</language><publisher>England: John Wiley & Sons, Inc</publisher><subject>Adherens junctions ; Cell adhesion & migration ; Cell migration ; E-cadherin ; Enzyme-linked immunosorbent assay ; Medical prognosis ; Melanoma ; Membrane proteins ; Mesenchyme ; MET ; Metastases ; Mimicry ; MMP‐2 ; myoferlin ; Original ; Prognosis ; siRNA ; Tumors ; vasculogenic mimicry ; Vimentin ; Western blotting</subject><ispartof>Journal of cellular and molecular medicine, 2018-03, Vol.22 (3), p.1743-1754</ispartof><rights>2017 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.</rights><rights>2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5145-2c1b50478c560ed14d39dbf2e9c6e63d9eff1c3231a10986a6637f0bc80579373</citedby><cites>FETCH-LOGICAL-c5145-2c1b50478c560ed14d39dbf2e9c6e63d9eff1c3231a10986a6637f0bc80579373</cites><orcidid>0000-0001-8869-7014</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2007380084/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2007380084?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,37013,44590,46052,46476,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29164766$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Wenxue</creatorcontrib><creatorcontrib>Zhou, Ping</creatorcontrib><creatorcontrib>Meng, Ai</creatorcontrib><creatorcontrib>Zhang, Rongxin</creatorcontrib><creatorcontrib>Zhou, Yan</creatorcontrib><title>Down‐regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP‐2 and inducing mesenchymal‐to‐epithelial transition</title><title>Journal of cellular and molecular medicine</title><addtitle>J Cell Mol Med</addtitle><description>Vasculogenic mimicry (VM) constitutes a novel approach for tumour blood supply and contributes to tumour metastasis and poor prognosis in patients with melanoma. Myoferlin (MYOF), a type II membrane protein involved in membrane regeneration and repair, is elevated in several malignant tumours, especially in advanced melanomas. This study aims to investigate the role and mechanism of MYOF in the regulation of VM. VM structures were found in 14 of 52 tested melanoma samples, and high MYOF expression correlated with VM structures. According to Kaplan–Meier survival curves, VM channels and elevated MYOF expression both correlated with poor prognosis in melanoma patients. Down‐regulation of MYOF by siRNA severely impaired the capability of A375 cells to form VM structures in vitro. Further studies demonstrated MYOF knockdown inhibited cell migration and invasion, which is required for VM formation, via decreasing MMP‐2 expression as evidenced by Western blotting, RT‐RCP and ELISA results. SB‐3CT, a specific inhibitor of MMP‐2, showed similar inhibiting effects with siMYOF, further supporting that MYOF down‐regulation inhibits MMP‐2 expression to affect VM formation. Moreover, MYOF knockdown suppress VM formation by A375 cells by inducing mesenchymal‐to‐epithelial transition (MET). After down‐regulating MYOF, focal adhesions were enlarged and A375 cells developed into a clear epithelial morphology. Such cells acquired the expression of E‐cadherin at adherens junctions along with a loss of mesenchymal markers, such as Vimentin and Twist1. In conclusion, MYOF plays an important role in VM and knockdown of MYOF suppresses VM formation via decreasing MMP‐2 and inducing MET in A375 melanoma cells.</description><subject>Adherens junctions</subject><subject>Cell adhesion & migration</subject><subject>Cell migration</subject><subject>E-cadherin</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Medical prognosis</subject><subject>Melanoma</subject><subject>Membrane proteins</subject><subject>Mesenchyme</subject><subject>MET</subject><subject>Metastases</subject><subject>Mimicry</subject><subject>MMP‐2</subject><subject>myoferlin</subject><subject>Original</subject><subject>Prognosis</subject><subject>siRNA</subject><subject>Tumors</subject><subject>vasculogenic mimicry</subject><subject>Vimentin</subject><subject>Western blotting</subject><issn>1582-1838</issn><issn>1582-4934</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><recordid>eNp9kctu1DAUhiMEoqWw4QGQJTYIaVo7dpx4g1QNlxZ1BAtYW45zMuORL4OdTJUdj8COLc_Co_AkeDrTCljghW35fPp0fP6ieErwKcnrbK2dOyWUVdW94phUTTljgrL7hztpaHNUPEppjTHlhIqHxVEpCGc158fF99fh2v_6-i3CcrRqMH6JFlPoIVrjkfEr05ohoWEFaKuSHm1YgjcaOeOMjhMK_c8fDqzywSm0NQp1oCOodONZfMziEinfZVM36t2jgwReryanbC4OIW-wMdlvjbJoiMonM5jgHxcPemUTPDmcJ8Xnt28-zS9mVx_eXc7Pr2a6IqyalZq0FWZ1oyuOoSOso6Jr-xKE5sBpJ6DviaYlJYpg0XDFOa173OoGV7WgNT0pXu29m7F10GnwuQcrN9E4FScZlJF_V7xZyWXYyjxaxsoyC14cBDF8GSEN0pmkweaZQBiTJILXjHMhmow-_wddhzH6_D1ZYlzTBuOGZerlntIxpBShv2uGYLnLW-7yljd5Z_jZn-3fobcBZ4DsgWtjYfqPSr6fLxZ76W-s0L5P</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Zhang, Wenxue</creator><creator>Zhou, Ping</creator><creator>Meng, Ai</creator><creator>Zhang, Rongxin</creator><creator>Zhou, Yan</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-8869-7014</orcidid></search><sort><creationdate>201803</creationdate><title>Down‐regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP‐2 and inducing mesenchymal‐to‐epithelial transition</title><author>Zhang, Wenxue ; Zhou, Ping ; Meng, Ai ; Zhang, Rongxin ; Zhou, Yan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5145-2c1b50478c560ed14d39dbf2e9c6e63d9eff1c3231a10986a6637f0bc80579373</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adherens junctions</topic><topic>Cell adhesion & migration</topic><topic>Cell migration</topic><topic>E-cadherin</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Medical prognosis</topic><topic>Melanoma</topic><topic>Membrane proteins</topic><topic>Mesenchyme</topic><topic>MET</topic><topic>Metastases</topic><topic>Mimicry</topic><topic>MMP‐2</topic><topic>myoferlin</topic><topic>Original</topic><topic>Prognosis</topic><topic>siRNA</topic><topic>Tumors</topic><topic>vasculogenic mimicry</topic><topic>Vimentin</topic><topic>Western blotting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Wenxue</creatorcontrib><creatorcontrib>Zhou, Ping</creatorcontrib><creatorcontrib>Meng, Ai</creatorcontrib><creatorcontrib>Zhang, Rongxin</creatorcontrib><creatorcontrib>Zhou, Yan</creatorcontrib><collection>Open Access: Wiley-Blackwell Open Access Journals</collection><collection>Wiley-Blackwell Backfiles (Open access)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cellular and molecular medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Wenxue</au><au>Zhou, Ping</au><au>Meng, Ai</au><au>Zhang, Rongxin</au><au>Zhou, Yan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Down‐regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP‐2 and inducing mesenchymal‐to‐epithelial transition</atitle><jtitle>Journal of cellular and molecular medicine</jtitle><addtitle>J Cell Mol Med</addtitle><date>2018-03</date><risdate>2018</risdate><volume>22</volume><issue>3</issue><spage>1743</spage><epage>1754</epage><pages>1743-1754</pages><issn>1582-1838</issn><eissn>1582-4934</eissn><abstract>Vasculogenic mimicry (VM) constitutes a novel approach for tumour blood supply and contributes to tumour metastasis and poor prognosis in patients with melanoma. Myoferlin (MYOF), a type II membrane protein involved in membrane regeneration and repair, is elevated in several malignant tumours, especially in advanced melanomas. This study aims to investigate the role and mechanism of MYOF in the regulation of VM. VM structures were found in 14 of 52 tested melanoma samples, and high MYOF expression correlated with VM structures. According to Kaplan–Meier survival curves, VM channels and elevated MYOF expression both correlated with poor prognosis in melanoma patients. Down‐regulation of MYOF by siRNA severely impaired the capability of A375 cells to form VM structures in vitro. Further studies demonstrated MYOF knockdown inhibited cell migration and invasion, which is required for VM formation, via decreasing MMP‐2 expression as evidenced by Western blotting, RT‐RCP and ELISA results. SB‐3CT, a specific inhibitor of MMP‐2, showed similar inhibiting effects with siMYOF, further supporting that MYOF down‐regulation inhibits MMP‐2 expression to affect VM formation. Moreover, MYOF knockdown suppress VM formation by A375 cells by inducing mesenchymal‐to‐epithelial transition (MET). After down‐regulating MYOF, focal adhesions were enlarged and A375 cells developed into a clear epithelial morphology. Such cells acquired the expression of E‐cadherin at adherens junctions along with a loss of mesenchymal markers, such as Vimentin and Twist1. In conclusion, MYOF plays an important role in VM and knockdown of MYOF suppresses VM formation via decreasing MMP‐2 and inducing MET in A375 melanoma cells.</abstract><cop>England</cop><pub>John Wiley & Sons, Inc</pub><pmid>29164766</pmid><doi>10.1111/jcmm.13455</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-8869-7014</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1582-1838 |
ispartof | Journal of cellular and molecular medicine, 2018-03, Vol.22 (3), p.1743-1754 |
issn | 1582-1838 1582-4934 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5824422 |
source | Open Access: PubMed Central; Publicly Available Content Database (Proquest) (PQ_SDU_P3); Open Access: Wiley-Blackwell Open Access Journals |
subjects | Adherens junctions Cell adhesion & migration Cell migration E-cadherin Enzyme-linked immunosorbent assay Medical prognosis Melanoma Membrane proteins Mesenchyme MET Metastases Mimicry MMP‐2 myoferlin Original Prognosis siRNA Tumors vasculogenic mimicry Vimentin Western blotting |
title | Down‐regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP‐2 and inducing mesenchymal‐to‐epithelial transition |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T14%3A37%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Down%E2%80%90regulating%20Myoferlin%20inhibits%20the%20vasculogenic%20mimicry%20of%C2%A0melanoma%20via%20decreasing%20MMP%E2%80%902%20and%20inducing%20mesenchymal%E2%80%90to%E2%80%90epithelial%20transition&rft.jtitle=Journal%20of%20cellular%20and%20molecular%20medicine&rft.au=Zhang,%20Wenxue&rft.date=2018-03&rft.volume=22&rft.issue=3&rft.spage=1743&rft.epage=1754&rft.pages=1743-1754&rft.issn=1582-1838&rft.eissn=1582-4934&rft_id=info:doi/10.1111/jcmm.13455&rft_dat=%3Cproquest_pubme%3E2007380084%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5145-2c1b50478c560ed14d39dbf2e9c6e63d9eff1c3231a10986a6637f0bc80579373%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2007380084&rft_id=info:pmid/29164766&rfr_iscdi=true |